author-photo

J. Xing

Bristol-Myers Squibb

6

Papers

697

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients

2012 American Journal of Transplantation
Show All
- Source
- Cite
- Save
Citations (248)
RENAL FUNCTION IN PATIENTS TREATED WITH BELATACEPT-OR CYCLOSPORINE-BASED REGIMENS AT YEAR 3 IN THE BENEFIT AND BENEFIT-EXT STUDIES

2011
Show All
- Source
- Cite
- Save
Citations (3)
Belatacept is associated with improved cardiovascular and metabolic risk factors compared to cyclosporine in kidney transplant patients (benefit and benefit-ext studies)

2009 Transplant International
Show All
- Source
- Cite
- Save
Citations (0)
Belatacept Is Associated with Improved Cardiovascular and Metabolic Risk Factors Compared to Cyclosporine in Kidney Transplant Patients (BENEFIT and BENEFIT-EXT Studies)

2009 American Journal of Transplantation
Show All
- Source
- Cite
- Save
Citations (0)